Eczema cream safety in pregnancy under scrutiny in massive new study
NCT ID NCT06627335
First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 21 times
Summary
This study looks at over 5,600 pregnant women with eczema to see if using ruxolitinib cream affects the baby's health compared to using standard steroid creams. Researchers will track birth defects, birth weight, and pregnancy outcomes using insurance claims data. The goal is to provide better safety information for women who need eczema treatment during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Syneos Health (remote site)
RECRUITINGMorrisville, North Carolina, 27560, United States
Conditions
Explore the condition pages connected to this study.